U.S., Sept. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07189403) titled 'A Study of DS9051b in Participants With Advanced or Metastatic Adrenocortical Carcinoma and Metastatic Castration-resistant Prostate Cancer' on Sept. 16.
Brief Summary: This FIH study is designed to assess the safety, tolerability, and preliminary efficacy signals of DS9051b in participants with ACC and mCRPC.
Study Start Date: Oct. 01
Study Type: INTERVENTIONAL
Condition:
Advanced or Metastatic Adrenocortical Carcinoma
Metastatic Castration-resistant Prostate Cancer
Intervention:
DRUG: DS9051b
Administered orally
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Daiichi Sankyo
Published by HT Digital Content Services with ...